Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Pulmonary/Respiratory Diseases | Trauma (Emergency, Injury, Surgery) | Immunology | Family Medicine

COPD (Chronic Obstructive Pulmonary Disease) Clinical Trials

A listing of COPD (Chronic Obstructive Pulmonary Disease) medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  ... Last 

Alabama

Research Site
Birmingham Alabama 35209

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Research Site
Birmingham Alabama 35216

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Achieve Clinical Research, LLC an Accel Research Site
Birmingham Alabama 35216

Long term safety study of QVA149 in COPD patients with moderate to sever airflow limitation.

View More »

GSK Investigational Site
Andalusia Alabama 36420

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Pearl Investigative Site
Andalusia Alabama

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

Pearl Investigative Site
Anniston Alabama

Patients are needed to participate in a clinical research study of GFF MDI (PT 003), GP MDI (PT001), FF MDI (PT005) and Open-label tiotropium bromide inhalation to evaluate Chronic Obstructive Pulmonary Disease (COPD)

UAB Lung Health Center
Birmingham Alabama 35294

A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease

Novartis Investigative Site
Birmingham Alabama 35205

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

GSK Investigational Site
Birmingham Alabama 35294

A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive

GSK Investigational Site
Birmingham Alabama 35242

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

GSK Investigational Site
Birmingham Alabama 35209

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

GSK Investigational Site
Birmingham Alabama 35233

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Pearl Investigative Site
Birmingham Alabama

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Forest Investigative Site 3836
Birmingham Alabama 35209
Updated

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Forest Investigative Site 3056
Birmingham Alabama 35209
Updated

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Pearl Investigative Site
Florence Alabama

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Forest Investigative Site 3438
Florence Alabama 35630
Updated

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Forest Investigative Site 3729
Foley Alabama 36535
Updated

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Novartis Investigative Site
Huntsville Alabama 35801

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

GSK Investigational Site
Huntsville Alabama 35801

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Forest Investigative Site 3911
Huntsville Alabama 35801
Updated

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

1237.26.10620 Boehringer Ingelheim Investigational Site
Jasper Alabama
Updated

A clinical research study for the treatment of Pulmonary Disease, Chronic Obstructive

Pearl Investigative Site
Jasper Alabama

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Forest Investigative Site 2423
Jasper Alabama 35501
Updated

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

GSK Investigational Site
Mobile Alabama 36608

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Pearl Investigative Site
Mobile Alabama

Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)

Forest Investigative Site 4030
Mobile Alabama 36604
Updated

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Novartis Investigative Site
Montgomery Alabama 36109

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

GSK Investigational Site
Montgomery Alabama 36109

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

GSK Investigational Site
Montgomery Alabama 36106

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

GSK Investigational Site
Ozark Alabama 36360

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

GSK Investigational Site
Pell City Alabama 35128

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

GSK Investigational Site
Pisgah Alabama 35765

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

GSK Investigational Site
Tuscumbia Alabama 35674

Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive

Arizona

Research Site
Flagstaff Arizona 86001

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Arizona Research Center
Phoenix Arizona 85023

A Long-Term, Randomized, Double-Blind Study of the Safety, Tolerability and Efficacy of Aclidinium Bromide At Two Dosage Levels When Administered to Patients With Moderate to Severe, Stable Chronic Obstructive Pulmonary Disease

Research Site
Phoenix Arizona 85381

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Research Site
Phoenix Arizona 85018

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Research Site
Phoenix Arizona 85020

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

Elite Clinical Studies, LLC
Phoenix Arizona 85018

Is COPD Leaving You Breathless? Right now we're enrolling adults with COPD ages 40 or older in a research study of an investigational medication for COPD.

Research Site
Tucson Arizona 85741

A Randomized, double-blinded, placebo controlled study to evaluate the safety of long term use of Performist (Formoterol fumarate) inhalation solution in subjects with Chronic Obstructive Pulmonary Disease (COPD).

View More »

Novartis Investigative Site
Additional Locations Arizona

A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)

Forest Investigative Site 4015
Chandler Arizona 85224
Updated

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Forest Investigative Site 3731
Chandler Arizona 85224
Updated

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Forest Investigative Site 3164
Chandler Arizona 85224
Updated

Patients are needed to participate in a clinical research study of Aclidinium Bromide and Placebo to evaluate COPD or Chronic Obstructive Pulmonary Disease

Clinical Trial Connection
Flagstaff Arizona 86001

A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease

First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  ... Last